Carpipramine
| Carpipramine | |
|---|---|
| Carpipramine.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Carpipramine is a typical antipsychotic medication primarily used in the treatment of schizophrenia and other psychotic disorders. It belongs to the class of tricyclic antipsychotics, which are known for their chemical structure and pharmacological properties.
Pharmacology[edit]
Carpipramine functions as a dopamine receptor antagonist, which means it blocks the action of dopamine in the brain. This action is believed to be responsible for its antipsychotic effects. By inhibiting dopamine receptors, particularly the D2 subtype, carpipramine helps to reduce the symptoms of psychosis, such as hallucinations and delusions.
Chemical Structure[edit]
Carpipramine is a tricyclic compound, characterized by its three-ring core structure. This structure is similar to that of other tricyclic antipsychotics and antidepressants, which contributes to its pharmacological profile.
Clinical Use[edit]
Carpipramine is prescribed for the management of schizophrenia and other psychotic disorders. It is typically used when other antipsychotic medications are not effective or cause intolerable side effects. The medication is administered orally, and the dosage is adjusted based on the patient's response and tolerance.
Side Effects[edit]
Like many antipsychotic medications, carpipramine can cause a range of side effects. Common side effects include sedation, dry mouth, constipation, and weight gain. More serious side effects may include extrapyramidal symptoms, such as tardive dyskinesia, and neuroleptic malignant syndrome, a rare but life-threatening condition.
Mechanism of Action[edit]
Carpipramine's primary mechanism of action is the blockade of dopamine receptors in the brain. This action reduces the overactivity of dopamine pathways, which is thought to be a contributing factor in the development of psychotic symptoms. Additionally, carpipramine may have effects on other neurotransmitter systems, including serotonin and norepinephrine, which could contribute to its therapeutic effects and side effect profile.
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
